(Q41227836)

reason for preferred rank

28 September 2017

title

Effect of thymosin in vitro on T cell levels during radiation therapy.Correlations with radiation portal and initial T cell levels (English)

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

21 April 2023

Effect of thymosin in vitro on T cell levels during radiation therapy: correlations with radiation portal and initial T cell levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

adaptive radiation therapy

21 April 2023

main subject

0 references

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

21 April 2023

author name string

Alexander JC Jr

5

1 reference

28 September 2017

D. E. Kenady

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

21 April 2023

P. B. Chretien

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

21 April 2023

C. Potvin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

21 April 2023

R. M. Simon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

21 April 2023

J. C. Alexander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

21 April 2023

A. L. Goldstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A402187

21 April 2023

language of work or name

English

0 references

publication date

1 February 1977

1 reference

full work available at URL

28 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

21 April 2023

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

21 April 2023

1 reference

28 September 2017

volume

39

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

642-652

1 reference

Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%3C642%3A%3AAID-CNCR2820390241%3E3.0.CO%3B2-V

Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone

21 January 2018

3

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Delayed hypersensitivity in patients treated by curative radiotherapyIts relation to tumor response and short-term survival

21 April 2023

4

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Annals of clinical research

21 April 2023

5

4

355

Braeman

1972

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Immunologic status in lung cancer

21 April 2023

6

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Lymphocyte stimulation in urologic cancer patients.

21 April 2023

7

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Effect of radiation therapy on mumps-delayed type hypersensitivity reaction in lymphoma and carcinoma patients

21 April 2023

8

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Depression of lymphocyte replicating ability in radiotherapy patients

21 April 2023

9

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis

21 April 2023

10

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Lymphocyte transformation and changes in leukocyte count: effects of anesthesia and operation

21 April 2023

12

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Thymus-dependent lymphocyte levels in bronchogenic carcinoma: Correlations with histology, clinical stage, and clinical course after surgical treatment

21 April 2023

14

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Impaired immunologic reactivity and recurrence following cancer surgery

21 April 2023

15

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course

21 April 2023

16

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

The effect of radical radiotherapy on delayed hypersensitivity and the inflammatory response

21 April 2023

18

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Use of Thymosin in the Treatment of Primary Immunodeficiency Diseases and Cancer

21 April 2023

19

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin)

21 April 2023

20

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

21 April 2023

21

27

98

Hersh

1967

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Purification and properties of bovine thymosin

21 April 2023

22

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Blood lymphocyte replicating ability as a measurement of radiation dosage

21 April 2023

23

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence.

21 April 2023

24

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Thymosin reconstitution of T cell deficits in vitro in cancer patients

21 April 2023

25

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes

21 April 2023

27

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer

21 April 2023

28

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Thymus-derived lymphocytes in patients with solid malignancies

21 April 2023

29

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms

21 April 2023

30

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus

21 April 2023

31

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients

21 April 2023

34

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Effect of therapeutic irradiation on lymphocyte transformation in lung cancer

21 April 2023

35

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Differentiation of population of peripheral blood lymphocytes into cells bearing sheep erythrocyte receptors in vitro by human thymic extract

21 April 2023

36

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

Thymosin activity in patients with cellular immunodeficiency

21 April 2023

37

1 reference

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C642::AID-CNCR2820390241%3E3.0.CO;2-V

21 April 2023

Identifiers

10.1002/1097-0142(197702)39:2<642::AID-CNCR2820390241>3.0.CO;2-V

1 reference

28 September 2017

1 reference